CNS Infections- Leprosy Flashcards

1
Q

Mycobacterium leprae (Leprosy, AKA Hansen’s Disease) primarily involves

A

involves peripheral nerves and skin in cooler regions of the body and mucus membranes and tissues of upper respiratory tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Leprosy is the most common treatable cause of __________

A

neuropathy in the world

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mycobacterium leprae description

A
  • 4 strains
  • Acid-fast bacillus rod (mycolic acids in cell wall),
  • Slow growth rate (estimated generation time is about 12 hours).
  • Cannot be cultivated in vitro (Never cultured in vivo for diagnostic purposes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

An obligate intracellular pathogen, which grows in:

A
  1. macrophages,
    2. histocytes of skin,
    3. Schwann cells of nerves.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Incidence in the world most often occurs in

A
  • Southeast Asia: India, Indonesia, Bangladesh, Myanmar (Burma).
  • The remaining cases are primarily in Brazil, Nigeria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Transmission is primarily from diseased patients (esp. those with lepromatous form) via:

A
  1. aerosol route from persons with the lepromatous form of disease.
  2. Mucous membranes or broken skin on the one person makes direct contact with skin lesions from persons with the lepromatous form of disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most common form of infection is

A

asymptomatic form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

With respect to Schwann cells (SC) The organism binds laminin-2 to alpha-dystroglycan on Schwann cells (these binding proteins are not found in CNS) to enter Schwann cells. Only infects __________

A

non-myelinating SC that surrounds bundles of small diameter sensory nerve fibers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Also causes demyelination of peripheral nerves, which activates myelin-forming SC to ___________ (this is a normal physiological process for myelin-forming SC).

A

de-differentiate & become non-myelinated

-These de-differentiated SC are now susceptible to infection by M. leprae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sensory nerve loss in initially confined to

A

to the skin rash (with losses to temperature greater than losses to pinprick and light touch. Proprioception and vibration modalities are often preserved).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sensory nerve loss progresses to

A

multiple mono-neuropathies with large nerve sensory and motor involvement and distal painless injuries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The nerves affected are primarily the pressure/trauma-dependent nerves, with the ulnar nerve at the elbow involved most often, followed in order by

A

the superficial radial cutaneous and median nerve at the wrist, sural, radial, Popliteal fossa - Common peroneal nerve, Great auricular nerve in the neck and branches of the facial nerve (facial paralysis/lagophthalmos)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Deep tendon reflexes generally ________

A

preserved because the muscle spindles and large-fiber nerves are not involved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

3 cardinal signs of disease

A
  1. Skin lesions.
  2. Skin anesthesia.
  3. Peripheral nerve enlargement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Peripheral nerve enlargement causes 3 things:

KNOW!!!

A
  1. **Deformities due to weakness and wasting of muscles (eg, claw hand or foot drop secondary to muscle weakness)
  2. **Sensory symptoms, such as diminished to complete loss of sensation, paresthesias in the distribution of affected nerves, and neuralgic pain when the nerve is struck or stretched.
  3. **Spontaneous painless blisters, burns, and trophic ulcers on hands and feet, post sensory loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Disease Classification is based on the immune response of host
Ridley Jopling classification:

A
  1. Tuberculoid (TT) form
  2. Lepromatous (LL) form
  3. Borderline (3) forms (borderline boarderline, BB, BT, BL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

To classify, World health organization uses:

A
  1. Paucibacillary (PB) leprosy is defined as five or fewer skin lesions without detectable bacilli on skin smears = TT form.
  2. Patients with only a single skin lesion are classified separately as single lesion PB = TT form.
  3. Multibacillary (MB) leprosy is defined as six or more lesions and may be skin smear positive = LL form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Tuberculoid (TT) form, is it contagious?

A

NO

19
Q

Tuberculoid (TT) form description

A
  • Damage to patient’s skin and nerves occur via CMI
  • Patients have a positive response to lepromin skin testing
  • sensory loss in the skin rash, multiple mono-neuropathies with large nerve sensory and motor involvement
  • There is no caseous necrosis observed in skin lesions but it may be present in peripheral nerves
20
Q

Skin lesion description in Tuberculoid form (TT)

A
  • *skin plaques**
  • granulomatous (CMI response to agent)
  • large, asymmetric, few in number
  • hypopigmented, flattened, dry, scaly center.
  • sharply demarcated, raised edge,
  • with no sensation in center of lesion or the whole area around the lesion due to invasion of the nerves
  • with few acid-fast organisms present.
  • lesions tend to destroy the normal skin organs such as sweat glands and hair follicles
21
Q

Skin lesions with TT are unique because

A

they have no sensation in center of lesion or the whole area around the lesion due to invasion of the nerves

22
Q

For TT, Sensory loss as described above with progress to multiple mono-neuropathies occasionally causes ___________

A

extreme pain beyond endurance

23
Q

Lepromatous (LL) form - Contagious, yes or no?

A

YES

24
Q

During Lepromatous (LL) form damage to patient occurs via __________: Macrophages infiltrate the infection site with histocytes and engulf large numbers of bacilli, fill-up with lipid debris from bacilli, and enlarge, they are then designated as ___________, and cause skin lesions but multiple, __________ lesions throughout the body (nerves, eyes, and internal organs in addition to the skin).

A

Innate immune response

“foamy macrophages”

symmetrically distributed

25
Q

During LL form, damage to patient occurs via Humoral immune response: _____________ is common → joints and kidney inflammation due to deposition of Ag-Ab complexes followed by inflammation – a _______ hypersensitivity response at these sites.

A

A polyclonal hypergammaglobulinemia

type III

26
Q

Nerve damage like TT form occurs – Sensory loss, however patients are specifically NON-responsive (anergic) to ____________ but is capable of a normal CMI response to other agents, including other mycobacteria.

A

lepromin (Ag) and/or the organism,

27
Q

Skin lesions are a cardinal sign of LL, due to the innate immune response:

A
  1. extensive
  2. raised (papular or nodular lepromas skin lesions)
  3. irregularly shaped, with poorly defined edges.
  4. bilaterally symmetrical,
  5. lesions can coalsces.
  6. high densities (109 → 1010 cells/g tissue) of M. leprae are present in each lesion.
28
Q

Other S/S of Lepromatous (LL) form

A
  • extensive tissue destruction (e.g., nasal cartilage [saddle nose], perforated nasal septum, swollen enlarged ear lobes) occurs.
  • loss of body hair.
  • arthralgias.
  • myalgias
  • redness of the eyes (cannot close eyelids/ lagophthalmos).
  • severe neuropathy & sensory loss →claw hand and foot drop
  • bone reabsorption & trauma result in loss of digits.
  • Kidney failure (most common cause of death)
29
Q

Borderline (3) forms (borderline (BB, BT, BL):

A
  1. Both types of lesions are present. Disease can go either way depending upon immune status of the patient.
  2. Most leprosy patients fall within the borderline forms
30
Q

During diagnosis, Full thickness skin biopsy specimen is taken and histology will show

A
  • if organized epithelioid granulomas are present the patient has TT form.
  • if “foamy macrophages” are present then patient has LL form.
  • If disorganized epithelioid granulomas are present, the patient has the borderline form LT
31
Q

Type of staining used? KNOW!

A

Acid-fast staining by Fite-Farco modification of the acid-fast (carbol fusin) stain of skin biopsy specimen from the advancing margin of an active lesion

32
Q

Acid Fast Stain will show

A

TT form- no bacilli are present (rare)

LL form- High densities of acid-fast bacilli

  • Numbers of bacilli falling within the range of a. and b. of above are present in a patient with boarderline form
  • Slit-skin smear can be used for semiquantitive enumeration of bacilli in skin to assess patients during and after treatment
33
Q

Lepromin test is observed both 2 or 3 days and then 3 to 4w after injection, results are expressed as size of induration in mm. This test is NOT used for:

A
  • Not diagnostic or prognostic (Not FDA approved, not available in the US)
  • Not used to monitor progress in therapy.
  • Not used to determine infection or exposure to M. leprae (low sensitivity & specificity).
  • Is a DTH response (a measure of lymphocyte/macrophage accumulation/proliferation at injection site).
  • Is used to assess disease form, but skin biopsy is preferred means to determine disease form
34
Q

Positive vs Negative Lepromin test

A
  • A negative response to the test is associated with a person with LL form
  • A positive response (actual granuloma formation) is associated with a person with TT form
35
Q

Multidrug therapy (MDT) is now the norm, due in part, to emerging resistance strains:

A
  1. dapsone (sulfanilamide) and either or both of the two below:
    - rifampin
    - clofazimine – a fat-soluble riminophenazine dye, antibacterial that inhibits DNA replication, anti-inflammatory and immunosuppressive, produces pink to brownish skin pigmentation in nearly all patients within a few weeks, as well as similar discoloration of most bodily fluids and secretions.
36
Q

Treatment time for TT vs LL

A

TT form: 6 months and 2 drugs.

LL form: 2 years and 3 drugs.

  • Patients are considered noninfectious within 1→2 weeks of treatment (usually after the first dose)
  • Monitor drug therapy with microscopic examination of stained skin smears
37
Q

Erythema nodosum leprosum (ENL) is believed to be due to ____________

A

massive release of bacterial antigens and can occur in absence of treatment
-Occurs in many patients within 1 y of initiation of effective treatment

38
Q

Erythema nodosum leprosum (ENL) is characterized by:

A
  • deep, tender, extremely painful, red papules or nodules (lepromas) on face, arms, thighs
  • a generalized systemic response including fever, joint pain, edema, proteinuria and malaise, neuritis
39
Q

NOT the same as

A

regular erythema nodosum

40
Q

Treatment for ENL

A
  1. Thalidomide (for lepromatous form, specifically to reduce occurrence of ENL; eliminates need for corticosteroid use)
  2. Clofazimine
41
Q

Prognosis for TT, LL and BT/BL

A

TT – good even without treatment, but treat anyway.
LL – poor without treatment
B – depends upon if patient is BT or BL

-high #s of bacilli post treatment= relapse is common

42
Q

Respiratory isolation is required for

A

LL and the indeterminate forms until chemotherapy becomes effective.

-No quarantine or hospitalization required for TT.

43
Q

Chemoprophylaxis is used for

A

close contacts

vaccine is available/approved in India, Brazil; can be preventative for neonates